Tag Archives: patents

With Botanicals, No Patent, No Expiry, says Sanofi Exec

By Ben Comer | Published: May 20, 2011
What if a new drug could be trademarked instead of patented, keeping generics companies at bay for the life of the trademark, i.e., forever? That was one of the ideas floated to reporters yesterday by Sanofi-Aventis’ Ray Jupp, VP of the fibrosis and wound repair therapeutic strategic unit, an early-stage research division created as part of [...]
Posted in R&D, Strategy | Also tagged , , , , | 3 Comments

Industry, Patents and Public Health: Wimps on the Barbie?

By William Looney | Published: October 20, 2010
The welcome news of a compact between industry and the WHO to fight neglected diseases in the developing world only highlights a much more spotty industry record of engagement on sensitive policy issues like intellectual property rights. One of the industry’s more ambitious policy-driven efforts occurred some five years ago with a strong, well-funded and broadly [...]
Posted in Corporate Responsibility, Global, Legal, R&D, Strategy | Also tagged , , , | 1 Comment

Authorized Generics Agreements to Increase

By Julian Upton | Published: July 29, 2009
Image by :: Wendy :: via Flickr The number of authorized generics (AG) agreements is likely to grow as pharma continues to converge with generics companies, a new report from Datamonitor claims. AG agreements are considered more ‘potent’ in the US market because market exclusivity is awarded to first-to-file generics companies, but detractors among the generics-producing [...]
Posted in Global, News, Regulatory | Also tagged , , , , , | 1 Comment